Dren

Dren bio

This biopharmaceutical company develops antibody therapeutics to treat patients with cancer, autoimmune conditions, and neurological diseases.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Arda Therapeutics

This biotechnology company develops targeted cell depletion therapies to treat chronic diseases by identifying and removing specific pathogenic cells in patients.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

EpiBiologics

This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.